Answers are grounded in this paper and cite their sources.
Clinical efficacy of cisplatin as antitumorous drug is indisputable; but its use is dose-limited due to its association with severe nephrotoxicity. The latest researches have demonstrated that epoetin alpha might have an important role not only in therapeutic aims for correction of different types of anemia, but in could also be efficient as neuroprotective, hepatoprotective, cardioprotective and especially as nephroprotective drug in neprhotoxicity induced by agents based on platinum. The main aim of this study was to determine the effect of epoetin alpha in prevention of nephrotoxicity induced experimentally in Wistar rats by long-term administration of cisplatin at dose of 2 mg/kg/b.w./per week during a period of 8 weeks. The results obtained have shown that epoetin alpha significantly alleviates the functional renal failure induced by long-term administration of cisplatin and improves the general condition as well as reduces the mortality in examined animals.
No takes yet. Share an insight, caveat, or question.
Zafirov et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: